Navin Saxena Research And Technology Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 30 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 30.00 Cr
as on 17-11-2024
- Revenue 6.46%
(FY 2023)
- Profit 46.53%
(FY 2023)
- Ebitda -9.27%
(FY 2023)
- Net Worth 85.60%
(FY 2023)
- Total Assets -3.84%
(FY 2023)
About Navin Saxena Research And Technology
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹30.00 Cr.
Kunal Saxena, Aakarsh Saxena, and Navin Sexena serve as directors at the Company.
- CIN/LLPIN
U73100MH1994PTC083220
- Company No.
083220
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Navin Saxena Research And Technology?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kunal Saxena | Director | 19-Apr-2013 | Current |
Aakarsh Saxena | Whole-Time Director | 08-Feb-2016 | Current |
Navin Sexena | Director | 23-Nov-1994 | Current |
Financial Performance of Navin Saxena Research And Technology.
Navin Saxena Research And Technology Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.46% increase. The company also saw a substantial improvement in profitability, with a 46.53% increase in profit. The company's net worth Soared by an impressive increase of 85.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Navin Saxena Research And Technology?
In 2023, Navin Saxena Research And Technology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Quantys Clinical Private LimitedActive 10 years 4 months
Kunal Saxena and Navin Sexena are mutual person
- Navicare Pharma Private LimitedActive 13 years 7 months
Kunal Saxena and Navin Sexena are mutual person
- Rusan Health Care Private LimitedActive 25 years 1 month
Kunal Saxena and Navin Sexena are mutual person
- Rusan Pharma LimitedActive 30 years 9 months
Kunal Saxena, Aakarsh Saxena and 1 more are mutual person
- Tuscany Holdings Private LimitedActive 30 years 2 months
Kunal Saxena and Navin Sexena are mutual person
- Euromed International Private LimitedActive 26 years 11 months
Kunal Saxena and Navin Sexena are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Icici Bank Limited Creation Date: 29 Sep 2015 | ₹30.00 Cr | Open |
How Many Employees Work at Navin Saxena Research And Technology?
Navin Saxena Research And Technology has a workforce of 75 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Navin Saxena Research And Technology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Navin Saxena Research And Technology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.